SCHEMBL6953508

SCHEMBL6953508

CC=CCC(C)NC(=S)Nc1nccs1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 4/20 0.45
ALDH1A1 P00352 4/20 0.45
RAB9A P51151 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
GAA P10253 3/20 0.45
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
PKM P14618 3/20 0.45
LMNA P02545 3/20 0.45
NPC1 O15118 2/20 0.45
NFKB1 P19838 2/20 0.45
NPSR1 Q6W5P4 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
MAPK1 P28482 1/20 0.45
CYP2C19 P33261 1/20 0.45
THPO P40225 1/20 0.45
MTOR P42345 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6963854 0.80 RAB9A (0.48) HTTALDH1A1RAB9ASMN1; SMN2GAA
SCHEMBL6965126 0.80 RAB9A (0.48) HTTALDH1A1RAB9ASMN1; SMN2GAA
SCHEMBL6963856 0.76 ALDH1A1 (0.47) HTTALDH1A1RAB9ASMN1; SMN2GAA
SCHEMBL6959647 0.74 ALDH1A1 (0.53) ALDH1A1RAB9ASMN1; SMN2GAAMEN1
SCHEMBL6959508 0.73 HPGD (0.49) HTTALDH1A1RAB9ASMN1; SMN2GAA
SCHEMBL6959347 0.72 ALDH1A1 (0.52) HTTALDH1A1RAB9ASMN1; SMN2MEN1
SCHEMBL6959240 0.72 NPC1 (0.53) HTTALDH1A1RAB9ASMN1; SMN2GAA
SCHEMBL6960348 0.72 LMNA (0.46) HTTALDH1A1RAB9ASMN1; SMN2GAA
SCHEMBL27283642 0.70 RAB9A (0.60) HTTALDH1A1RAB9ASMN1; SMN2GAA
SCHEMBL6281076 0.69 NPC1 (0.52) HTTALDH1A1RAB9ASMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0540143-B1 Compounds and methods for inhibition of HIV and related viruses MEDIVIR AB (SE) 2003-02-05 EP disclosed
US-5658907-A THIOUREA VIRICIDES MEDIVIR A/B (SE) 1997-08-19 US disclosed
US-5593993-A VIRICIDES FOR HTLV TREATMENT OF AIDS MEDIVIR AB (SE) 1997-01-14 US disclosed
EP-0540143-A2 Compounds and methods for inhibition of HIV and related viruses Medivir Aktiebolag (SE) 1993-05-05 EP disclosed